BULLETIN V2026-2808
RAKOVINA THERAPEUTICS INC. ("RKV")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: September 2, 2026
TSX Venture Tier 2 Company
Financing Type: Non-Brokered Private Placement
Gross Proceeds: $1,991,000.00
Offering: 19,910,000 Listed Shares with 9,955,000 warrants attached
Offering Price: $0.10 per Listed Share
Warrant Exercise Terms: $0.20 per Listed Share for a two-year period.
Commissions in Securities:
Shares
Warrants
Finders (Aggregate)
0
1,117,250
Commission Terms: Each warrant unit entitles the holder to acquire one Listed Share at a price of $0.10 per Listed Share and one-half of one share purchase warrant, with each whole warrant exercisable to acquire one additional Listed Share at a price of $0.20 per Share, in each case for a period of 24 months from the date of issue.
Disclosure: Refer to the company's news releases dated July 15, 2026, August 12, 2026 and August 31, 2026.
_______________________________________
|
|
